Development and Evaluation of New TB Diagnostics

Project Coordinator: Andrea Rachow, MD

In collaboration with FIND-Diagnostics (Geneva), Chemogen Inc. (USA), University College London (UCL), University of Cape Town (UCT) and other partners, new diagnostics for simple and rapid detection of TB and drug resistance in adults and children are being developed and evaluated.

Currently, the portfolio in evaluation comprises PCR-based methods directly from smear positive sputum or positive culture, such as Xpert MTB/RIF Assay®, Hain MTBDRplus® and LAMP. Additionally we further evaluate IFN-y release assays (IGRAs) and different ELISAs for their performance in detection of childhood TB. Moreover new markers for TB treatment course and their capability of predicting treatment outcome are under investigation. Together with UCL transrenally excreted mycobacterial DNA is evaluated as biomarker for anti TB- treatment course. Furthermore TB-diagnosis by stool PCR will be established at the site with the aim to improve DNA-extraction methods and diagnostic accuracy of existing PCR-strategies. In a joined research project with UCT out of other research question the performance of a new generation of urine LAM-ELISA and its impact on TB-diagnostic in resource constrained countries is investigated.

As reference standard we use culture on solid and liquid media followed by molecular species determination and drug susceptibility testing using the Bactec MGIT-system performed in our state-of-the art tuberculosis laboratory.

 

You can reach us at:

NIMR - Mbeya Medical Research Center
P.O Box 2410
Hospital Hill rd, Mbeya Tanzania

Tel +255 25 250 3364
Fax +255 25 250 3134

Working hours:
Mon - Fri
08:00 - 17:00 EAT (GMT + 3)

Or send us an email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Our Twitter Feed

NIMRMbeya The site Initiation of the EDCTP funded LIFE project in Tanzania: The study team at the Tanzanian National Institut… https://t.co/FfVS2YGy2G
NIMRMbeya Site initiation visit for Holistic Approach to Unravel Antibacterial Resistance in East Africa #HATUA study at NIMR… https://t.co/ciG1psDCu0
NIMRMbeya RT @MHRPInfo: This week MHRP @wrair is participating in the annual HVTN meeting in Washington, D.C. Here, Deputy Director LTC Julie Ake tal…
NIMRMbeya Maria Mwakatima reviewing an article by Kyle D. Smith et al on "Increased Antifungal Drug Resistance in Clinical Is… https://t.co/9Z2GYTiZPp
© 2017 NIMR - Mbeya Medical Research Center